ACCO Brands (ACCO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Full-year 2024 net sales were $1.67 billion, down 9.1% year-over-year, with adjusted EPS at $1.02 and gross margin up 70 basis points to 33.3%, meeting outlook despite adverse FX impacts.
Free cash flow reached $132 million, up $17 million year-over-year, supported by cost actions and improved working capital, including a 17% inventory reduction.
Net debt reduced by $94 million, enabling $15 million in share repurchases and $28 million in dividends, and expanding M&A consideration.
Strategic initiatives included a $60 million multi-year cost reduction program, expanded to $100 million by 2026, with $25 million realized in 2024.
Focus remains on cost optimization, new product development, brand building, and accretive acquisitions.
Financial highlights
Net sales for 2024 were $1.67 billion, down 9.1% year-over-year; Q4 net sales were $448.1 million, down 8.3%.
Adjusted operating income for 2024 was $189.7 million (11.4% margin), down 7.4% year-over-year; adjusted EPS was $1.02, down 6.4%.
Gross margin improved to 33.3%, up 70 basis points from prior year; SG&A costs down nearly $30 million.
Free cash flow for the year was $132 million; net debt ended at $766 million.
Consolidated leverage ratio at year-end was 3.4x, below the 4x covenant.
Outlook and guidance
2025 comparable sales expected to decline 1%-5%, with improvement anticipated as the year progresses.
Adjusted EPS for 2025 projected at $1.00-$1.05; gross margins expected to improve.
Free cash flow guidance for 2025 is $105-$115 million; leverage ratio targeted at 3.0x–3.3x by year-end.
Q1 2025 comparable sales forecasted down 5%-8%, with a loss per share of $0.03-$0.05.
Broader guidance range reflects economic uncertainty, FX, tariffs, and geopolitical instability.
Latest events from ACCO Brands
- 2026 proxy covers director elections, auditor ratification, executive pay, and incentive plan amendment.ACCO
Proxy filing27 Mar 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and incentive plan amendment.ACCO
Proxy filing27 Mar 2026 - 2025 results met outlook with $1.525B sales, $0.84 EPS, and a strategic tech pivot.ACCO
Q4 20259 Mar 2026 - Adjusted EPS beat outlook as cost actions offset sales decline and impairment charges.ACCO
Q2 20242 Feb 2026 - Q3 sales fell 6%, but cost savings, cash flow, and margins improved despite impairment charges.ACCO
Q3 202417 Jan 2026 - 2025 proxy covers director elections, auditor ratification, compensation, and incentive plan amendment.ACCO
Proxy Filing1 Dec 2025 - Shareholders will vote virtually in May 2025 on directors, auditor, pay, and plan amendment.ACCO
Proxy Filing1 Dec 2025 - Shareholders to vote virtually on directors, auditor, compensation, and incentive plan amendment.ACCO
Proxy Filing1 Dec 2025 - Sales fell 11.6%, but gross margin and adjusted EPS beat expectations amid market headwinds.ACCO
Q1 202528 Nov 2025